Surgical Adhesives in Facial Plastic Surgery
|
|
- Lucas Farmer
- 6 years ago
- Views:
Transcription
1 Surgical Adhesives in Facial Plastic Surgery Dean M. Toriumi, Victor K. Chung, Quintin M. Cappelle University of Illinois at Chicago Chicago, IL Supplement to Toriumi DM, Chung VK, Cappelle QM. Surgical adhesives in facial plastic surgery. Otolaryngologic Clinics, Volume 49, Issue Elsevier Inc. All rights reserved.
2 Why is bleeding a problem in facial plastic surgery? Skin flap injury from cautery Extended operative time Delayed wound healing Poor aesthetic outcome Return to operating room
3 Categories of Surgical Tissue Adhesives Cyanoacrylates Fibrin tissue adhesives
4 Cyanoacrylates Superficial wound closure No hemostatic property, only a tissue adhesive Elicit foreign body reaction when placed subdermally Longer chains derivatives demonstrate decreased toxicity E.g. Dermabond (Ethicon, Somerville, NJ)
5 Fibrin Tissue Adhesives Mechanism of action occurs on the coagulation cascade, replicating the body s natural hemostasis pathway Conversion of fibrinogen to fibrin initiates clot formation Fibrin Tissue Adhesives are composed of 2 components that activate when mixed together
6 Coagulation Pathway Extrinsic and Intrinsic Pathways give way to the Common Pathway The last step in the common pathway is the conversion of fibrinogen to fibrin Fibrinogen in the plasma is converted to fibrin in the presence of thrombin and calcium chloride Factor XIII catalyzes fibrin molecules to cross-link to form a clot
7 Fibrin Tissue Adhesive Components Component 1 Fibrinogen, calcium chloride, Factor XIII Component 2 Thrombin and anti-fibrinolytic agent Component 1 Component 2 Fibrinogen Factor XIII Calcium Chloride Anti-fibrinolytic Thrombin Fibrin Sub-units Stable Fibrin Clot
8 Optimal Concentrations of Thrombin Thrombin concentration is proportional to the rate of polymerization High Thrombin concentration = rapid polymerization and hemostasis >500 U/mL Low thrombin concentration = slower polymerization and time for flap manipulation U/mL
9 Methods of Application Single Barrel Syringe Less uniform mixing Cumbersome Double Barrel syringe Clogging issues Gas-Pressurized Spray Requires pressurized air source Increased expense A B
10 Autologous Fibrin Tissue Adhesives Patient s own blood, autologous Collected pre-operatively No risk of disease transmission or immune reaction Centrifugation isolates the platelet-rich plasma layer Fibrinogen collected at a natural concentration Combined with pre-made mixture of thrombincalcium chloride Low risk of factor V cross-reactivity with bovine thrombin Selphyl device (Aesthetic Factors, LLC, Princeton, NJ)
11 Homologous Fibrin Tissue Adhesives Pooled donors, homologous Greater concentration of fibrinogen compared to plateletrich plasma Identical substrates of fibrinogen, thrombin, calcium chloride, Factor XIII Theoretical risks associated with homologous products (transmission of HIV and hepatitis) E.g. Tisseel and Artiss (Baxter Healthcare Corp., Deerfield, IL); Evicel (formerly Crosseel) (Omrix Biopharmaceuticals, Israel)
12 Risk of Viral Transmission from Homologous Products 1 reported case of B19 parvovirus transmission Risk estimated at 1:500,000 No reported cases of HIV, Hepatitis B, or Hepatitis C Risk estimated at < 1x10 15
13 What are the proposed benefits of fibrin tissue adhesives in facial plastic surgery? Improved hemostasis Expedited operating time Decreased edema Decreased ecchymosis Expedited postoperative recovery
14 FDA Off-label Use Fibrin combined with thrombin since 1944 FDA approval in 1998 Artiss (Baxter Healthcare Corp., Deerfield, IL) Adhere autologous skin grafts to surgically prepared wound beds resulting from burns in adult and pediatric populations Tisseel (Baxter Healthcare Corp., Deerfield, IL): Prevent leakage from colonic anastomoses, adjunct to hemostasis in adults and pediatric patients undergoing surgery Evicel (formerly Crosseel) (Omrix Biopharmaceuticals, Israel) Adjunct to hemostasis in patients undergoing liver surgery
15 A Applications in B Facial Plastic and Reconstructive Surgery Historic use 1944 first application Grafts & Flaps Obliterates dead space Promotes hemostasis C Decreases seroma formation Aids in neovascularization of graft or flap
16 Optimal Application Thickness Higher skin graft survival with thin application of fibrin sealant (vs. thicker application) Similar survival between thin application group and the control Decreased survival with thicker application versus the control Fibrinogen concentration did not affect skin graft survival Critical for grafts, but less important for well-vascularized flaps Thinner layer FTA Thicker FTA
17 Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Rhytidectomy Randomized, prospective, blinded trials trend toward reduced drainage from indwelling suction drains and no effect on hematoma Retrospective (large) reduced hematoma rate in fibrin sealant group 3.4% vs 0.4%; p = 0.01 Sequential trials with unilaterally treated face: reduced both drainage and hematoma Fibrin glue reduced drainage but there was no difference in hematoma rates
18 Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Rhytidectomy Technique: Lower thrombin concentration Skin flaps are designed and tailored Fixation sutures are placed, but not tied Pressurized spray application Skin flap is positioned Sutures are tied Pressure applied No drain placement Courtesy of Baxter; Deerfield, IL; with permission.
19 Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Endoscopic Forehead Lift Technique Subperiosteal dissection Release of arcus marginalis Division of procerus and corrugator muscles Temporal dissection and lateral suture fixation Fixation with suture and fibrin tissue adhesive Fixation sutures are placed but not tied 2mL of homologous fibrin tissue adhesive along orbital rim and on divided muscles Normal thrombin concentration 15 cm malleable double-barrel applicator tip Fixation sutures are tied Pressure to glabella 5-10 minutes Courtesy of Baxter; Deerfield, IL; with permission.
20 Fibrin Tissue Adhesive Use in Facial Plastic Surgery: Selecting Cases Recommended for use in case by case basis Excess intraoperative bleeding Augmenting traditional fixation No supported role in rhinoplasty
BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS AT AORN MEETING
FOR IMMEDIATE RELEASE Media Contact Beth Mueller, (224) 948-5353 media@baxter.com Investor Contact Clare Trachtman, (224) 948-3085 BAXTER UNVEILS DESIGN ENHANCEMENTS TO FLOSEAL AND TISSEEL HEMOSTATIC AGENTS
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)
European Medicines Agency Evaluation of Medicines for Human Use London, 29 July 2004 CPMP/BPWG/1089/00 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE CLINICAL INVESTIGATION OF PLASMA
More informationARTISS PROVIDES TIME FOR THE FINISHING TOUCH. [Solutions for Sealant] Application and Benefi ts in Burn Surgery
PROVIDES TIME FOR THE FINISHING TOUCH Full surface adherence eliminating dead space 3 Application and Benefi ts in Burn Surgery b Specifically Designed b ARTISS is indicated as a tissue glue to adhere/seal
More informationPRODUCT MONOGRAPH ARTISS. Fibrin Sealant (Human), Vapor Heated, Solvent/Detergent Treated 4 IU (Slow Set)
PRODUCT MONOGRAPH Pr ARTISS Fibrin Sealant (Human), Vapor Heated, Solvent/Detergent Treated 4 IU (Slow Set) Frozen Solutions for Thawing for Topical Application Hemostatic and Tissue Adhesive Agent Baxter
More informationCoagulation in perspective: Blood management. Objectives
Coagulation in perspective: Blood management Julie Wegner, PhD jawrbl@gmail.com Objectives To gain a basic understanding of the following: 1. Coagulation components and processes Why patients bleed. 2.
More informationSUMMARY OF PRODUCT CHARACTERISTICS
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT ARTISS Solutions for Sealant Deep frozen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Component 1: Sealer Protein Solution Human Fibrinogen
More informationBAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL PRODUCTS
FOR IMMEDIATE RELEASE Media Contact: Beth Mueller, (224) 948-5353 media@baxter.com Investor Contact: Clare Trachtman, (224) 948-3085 BAXTER ANNOUNCES AGREEMENT TO BROADEN PORTFOLIO OF INNOVATIVE SURGICAL
More informationAfter mixing 1 ml 2 ml 4 ml 10 ml Component 1: Sealer protein solution mg 1,500 KIU 2 IU
1. NAME OF THE MEDICINAL PRODUCT ARTISS Solutions for Sealant Deep frozen 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Component 1: Sealer Protein Solution Human Fibrinogen (as clottable protein) Aprotinin
More informationPhysiology Unit 3 HEMATOLOGY
Physiology Unit 3 HEMATOLOGY In Physiology Today Hematocrit Percentage of blood volume that is erythrocytes 45% in men 42% in women Average blood volume in is 5 L Plasma Large amounts of organic/inorganic
More informationTHE USE OF GLUES FOR HERNIA REPAIR RAMSEY MALULEKE, DEPARTMENT OF SURGERY, UNIVERSITY OF PRETORIA AND STEVE BIKO ACADEMIC HOSPITAL
THE USE OF GLUES FOR HERNIA REPAIR RAMSEY MALULEKE, DEPARTMENT OF SURGERY, UNIVERSITY OF PRETORIA AND STEVE BIKO ACADEMIC HOSPITAL OPTIONS FOR MESH FIXATION IN HERNIA REPAIR Tackers/staples Stitches Fibrin
More informationDoes Fibrin Sealant Reduce Seroma after Immediate Breast Reconstruction Utilizing a Latissimus Dorsi Myocutaneous Flap?
Does Fibrin Sealant Reduce Seroma after Immediate Breast Reconstruction Utilizing a Latissimus Dorsi Myocutaneous Flap? Original Article Han Gyu Cha, Sang Gue Kang, Ho Seong Shin, Moon Seok Kang, Seung
More informationTISSEEL [Fibrin Sealant] For Topical Use Only Frozen solution and lyophilized powder for solution for topical application Initial U.S.
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TISSEEL safely and effectively. See full prescribing information for TISSEEL. TISSEEL [Fibrin Sealant]
More informationThe Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery
PLASTIC & RECONSTRUCTIVE SURGERY. 2001 Jan; 107(1):229-37; discussion 239-9. The Use of Autologous Platelet-Rich Plasma (Platelet Gel) and Autologous Platelet-Poor Plasma (Fibrin Glue) in Cosmetic Surgery
More informationAutologous Fibrinogen Purification and Concentration For Use in Fibrin Sealant
Brigham Young University BYU ScholarsArchive All Theses and Dissertations 2005-06-08 Autologous Fibrinogen Purification and Concentration For Use in Fibrin Sealant Steven M. Alston Brigham Young University
More informationA review of Dr. Dinakar Golla s clinical research with AdMatrix surgical grafts for soft tissue repair
TEAMeffort: Using aggressive surgical techniques in combination with AdMatrix (Lattice Biologics acellular dermal scaffold product) to heal difficult and persistent wounds A review of Dr. Dinakar Golla
More informationPrimary hemostasis. Vascular endothelium Vasoconstriction : local tissue factor, nervous system
Primary hemostasis Vascular endothelium Vasoconstriction : local tissue factor, nervous system Platelet Plug Platelet Adhesion Platelet Activation Platelet Aggregation Platelet Plug Formation Secondary
More informationCoagulation Mechanisms Dr. Nervana Bayoumy
Coagulation Mechanisms Dr. Nervana Bayoumy Associate Professor Department of Physiology Objectives At the end of this lecture you should be able to: 1. Recognize the different clotting factors 2. Understand
More informationA.P.A.G. Activated Plasma Albumin Gel
A.P.A.G. Activated Plasma Albumin Gel How Does This Work In a new wound, platelets are the first cells which arrive. They aggregate to stop the bleeding and then release substances (growth factors, cytokines,
More informationTHROMBIN-JMI (Thrombin, Topical (Bovine) U.S.P.), Solution for topical use Initial U.S. Approval: 1986
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use THROMBIN-JMI safely and effectively. See full prescribing information for THROMBIN-JMI. THROMBIN-JMI
More informationALLODERM SELECT ALLODERM SELECT RESTORE
ALLODERM SELECT ALLODERM SELECT RESTORE Regenerative Tissue Matrix Instructions for Use Processed from donated human tissue by: LifeCell Corporation One Millennium Way Branchburg, NJ 08876-3876 DESCRIPTION
More informationInstructions for Use READY TO USE
READY TO USE Instructions for Use LifeCell Corporation One Millennium Way Branchburg, NJ 08876-3876 1.908.947.1215 1.800.367.5737 Fax: 1.908.947.1089 E-mail: customerservicegroup@lifecell.com www.lifecell.com
More informationORIGINAL ARTICLE. The Use of Fibrin Glue in the Correction of Pollybeak Deformity
The Use of Fibrin Glue in the Correction of Pollybeak Deformity A Preliminary Report ORIGINAL ARTICLE Krzysztof Conrad, MD, FRCS, FRCSC; Adi Yoskovitch, MD, MSc Background: Supratip fullness, also known
More informationSee 17 for PATIENT COUNSELING INFORMATION Revised: 01/2012 FULL PRESCRIBING INFORMATION: CONTENTS *
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use safely and effectively. See full prescribing information for. [Fibrin Sealant] For Topical Use Only
More informationXcede Technologies, Inc. Dynasil Corporation of America Annual Meeting of Stockholders. Peter Sulick, Chairman, President and CEO February 26, 2015
Xcede Technologies, Inc. Dynasil Corporation of America Annual Meeting of Stockholders Peter Sulick, Chairman, President and CEO February 26, 2015 Forward-Looking Statements The statements made in this
More informationIntroduction Hemostasis: Tourniquet Test & Bleeding Time. Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO
Introduction Hemostasis: Tourniquet Test & Bleeding Time Hematology-Immunology System Faculty of Medicine Universitas Padjadjaran LOGO Hemostasis A series of reactions that function to stop bleeding, maintaining
More informationEach 7.0 cm x 7.0 cm dressing contains 140 to 260 mg of human fibrinogen and 130 International Units of human thrombin.
SurgiClot Hemostatic Dressing St. Teresa Medical, Inc. 2915 Waters Road, Suite 108 Eagan, Minnesota 55121 USA Tel: 651-789-6550 www.stteresamedical.com INSTRUCTIONS FOR USE DEVICE DESCRIPTION Each SurgiClot
More informationAutologous Thrombin: Intraoperative Production From Whole Blood
The Journal of The American Society of Extra-Corporeal Technology Autologous Thrombin: Intraoperative Production From Whole Blood Vijay Kumar, PhD; John R. Chapman, PhD Thermogenesis Corporation, Rancho
More informationCan Platelet-Rich Plasma Therapy Help Surgery Patients Heal Faster?
Can Platelet-Rich Plasma Therapy Help Surgery Patients Heal Faster? Sari Murray and Stacey Twisdale, Master of Surgical Assisting Students, Class of 2016, Eastern Virginia Medical School, Norfolk, VA Nervous,
More informationTITLE: Recombinant Human Thrombin: Clinical Effectiveness And Cost-Effectiveness
TITLE: Recombinant Human Thrombin: Clinical Effectiveness And Cost-Effectiveness DATE: 08 November 2010 CONTEXT AND POLICY ISSUES: Excessive bleeding during surgical procedures can lead to increased morbidity
More informationROLE OF FIBRIN SEALANT IN PREVENTION OF HANGING PALATE OUR EXPERIENCE. Elankumar S, Chittoria R K *
Plastic Surgery Case Report International Journal of Clinical And Diagnostic Research ISSN 2395-3403 Volume 6, Issue 2, Mar-April 2018 ROLE OF FIBRIN SEALANT IN PREVENTION OF HANGING PALATE OUR EXPERIENCE
More informationGeneral Principles of. Hemostasis. Kristine Krafts, M.D.
General Principles of Hemostasis Kristine Krafts, M.D. Hemostasis is a balancing act! pro-ting plugs up holes in blood vessels anti-ting keeps ting under control Pro-Clotting Pro-Clotting vessels platelets
More informationHemostasis. by Mohie-Aldien Elsayed
Hemostasis by Mohie-Aldien Elsayed Hemostasis Hemostasis is defined as the process that maintains the flowing blood in a fluid state and confined to the circulatory system Coagulation prevents excess blood
More informationGuideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products
1 2 3 18 December 2013 EMA/CHMP/BPWP/598816/2010 rev. 1 Committee for Medicinal Products for Human Use (CHMP) 4 5 6 Guideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products Draft
More informationComparative Study Between Fibrin Glue Prepared from a Single Human Donor and Sutures for Sealing Induced Corneal Penetrating Wounds on Porcine Eyes
Original Article Philippine Journal of OPHTHALMOLOGY Comparative Study Between Fibrin Glue Prepared from a Single Human Donor and Sutures for Sealing Induced Corneal Penetrating Wounds on Porcine Eyes
More informationPresenting SURGICEL Powder
SURGICEL Powder Presenting SURGICEL Powder Built to stop continuous, broad-surface oozing fast1,2 The next generation of SURGICEL Absorbable Hemostats SURGICEL Powder efficiently and effectively controls
More informationAdv Pathophysiology Unit 4 Page 1 of 10. Learning Objectives for this file:
Adv Pathophysiology Unit 4 Page 1 of 10 Learning Objectives for this file: Topics include structure & function of: 1. Coagulation process platelets, clotting factors 2. Coagulation cascade formation of
More informationINSTRUCTIONS FOR USE FOR:
INSTRUCTIONS FOR USE FOR: en English INSTRUCTIONS FOR USE GORE ENFORM INTRAPERITONEAL BIOMATERIAL Carefully read all instructions prior to use. Observe all instructions, warnings, and precautions noted
More informationADHESIVE SEALANT BIOMATERIALS
ADHESIVE SEALANT BIOMATERIALS Technical Bulletin David Mandley PhD Tissuemed Ltd. Performance of a Novel Adhesive Film (TissuePatch TM 3) compared with commercially available Products in the resolution
More informationDiscover TruPRP. PRP the way you want it.
Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet
More informationDiscover TruPRP. PRP the way you want it.
Discover TruPRP PRP the way you want it. Discover TruPRP Discover the quality of Magellan TruPRP. The Magellan technology provides an automated dual spin processing system that can deliver (PRP) Platelet
More informationGet the most out of Pure PRP
Get the most out of Pure PRP The Basic Science of PRP Platelets are small non-nucleated bodies in peripheral blood known for role in hemostasis Platelets contain proteins, cytokines & other bioactive factors
More informationBusiness Review Deutsche Bank Conference May 4, Gary Pruden Company Group Chairman Worldwide Franchise Chairman Ethicon
Business Review Deutsche Bank Conference May 4, 2010 Gary Pruden Company Group Chairman Worldwide Franchise Chairman Ethicon Safe Harbor Statement This presentation may contain forward looking statements
More informationARTISS. NAME OF THE MEDICINE Two-Component Fibrin Sealant, Deep-Frozen, Vapour Heated (VH) and Solvent Detergent (S/D) treated.
ARTISS NAME OF THE MEDICINE Two-Component Fibrin Sealant, Deep-Frozen, Vapour Heated (VH) and Solvent Detergent (S/D) treated. DESCRIPTION ARTISS is a two-component fibrin sealant made from pooled human
More informationGuideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products
25 June 2015 EMA/CHMP/BPWP/598816/2010 rev. 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on core SmPC for plasma-derived fibrin sealant/ haemostatic products Draft Agreed by Blood
More informationAddressing Surgical Bleeding Situations With Adjunctive Hemostats *
Addressing Surgical Bleeding Situations With Adjunctive Hemostats * Intraoperative bleeding Continuous oozing Will not stop with compression/simple packing. The solution for this bleeding is more time
More informationLABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY
LABORATORY APPROACH TO BLEEDING DISORDERS DR NISHANTH PG 1 ST YEAR DEPARTMENT OF PATHOLOGY 1 WHEN IS THE LAB REQUIRED TO INVESTIGATE FOR A POSSIBLE BLEEDING DISORDER? Clinically suspected bleeding tendency
More informationThe Power in You. TM
RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The Power in You. TM Biologics Concentrated on Healing RegenKit THT Autologous Platelet Rich Plasma (A-PRP) The RegenKit THT is designed to be used
More informationEnzymatic Hydrolysis of Silk Fibroin Peptide for Hemorrhage Control
2015 2 nd International Conference on Material Engineering and Application (ICMEA 2015) ISBN: 978-1-60595-323-6 Enzymatic Hydrolysis of Silk Fibroin Peptide for Hemorrhage Control Jingjing Li 1,2, Hailin
More informationPlasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems.
Test Plasma Testing in the Clinical Coagulation Laboratory: New drugs, new problems. Karen A. Moffat BEd, MSc, ART, FCSMLS(D) Technical Specialist, Coagulation, HRLMP Assistant Professor, Department of
More informationAUSTRALIAN PRODUCT INFORMATION ARTISS (APROTININ, FACTOR XIII, FIBRINOGEN, THROMBIN, CALCIUM CHLORIDE DIHYDRATE)
AUSTRALIAN PRODUCT INFORMATION ARTISS (APROTININ, FACTOR XIII, FIBRINOGEN, THROMBIN, CALCIUM CHLORIDE DIHYDRATE) 1 NAME OF THE MEDICINE Aprotinin (synthetic), factor XIII, fibrinogen, thrombin and calcium
More informationSafe Harbor Statement
Safe Harbor Statement This presentation may contain forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of
More informationAdhesive Use in Oral and Maxillofacial Surgery
Adhesive Use in Oral and Maxillofacial Surgery Michael J. Buckley, DMD, MBA, MS a,b, *, Eric J. Beckman, PhD c,d KEYWORDS Tissue adhesives Adhesives for bone fixation Cyanoacrylates Fibrin sealants Collagen-based
More informationHome Study Program. Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients T
Home Study Program OCTOBER 2004, VOL 80, NO 4 Home Study Program Intraoperative use of autologous platelet-rich and platelet-poor plasma for orthopedic surgery patients T he article Intraoperative use
More informationSurgery* a network linking collagen and glycosaminoglycans (normal components of tissue matrix) in such a way
Human Fibrin Glue Versus Sutures in Periodontal Surgery Giovan Paolo Pini Prato, Pierpaolo Cortellini, Giancarlo Agudio and Carlo Clauser Accepted for publication 2 September 1986 A fibrinsealing system
More informationFibrin Glue in Skin grafts for Skin cancer (FiGSS): Open randomised clinical trial
Fibrin Glue in Skin grafts for Skin cancer (FiGSS): Open randomised clinical trial Principal investigator Ekta Paw BSc MBBS Principal House Officer (Surgery) The Townsville Hospital E-mail: ektapaw@gmail.com
More informationFixation of split thickness skin graft using fast clotting fibrin glue containing undiluted high concentration thrombin or sutures: a comparison study
DOI 10.1186/s40064-016-3599-x RESEARCH Open Access Fixation of split thickness skin graft using fast clotting fibrin glue containing undiluted high concentration thrombin or sutures: a comparison study
More informationClotalyst. Autologous Activation Solution. Surgical Technique
Clotalyst Autologous Activation Solution Surgical Technique Table of Contents Product Overview... 1-2 Processing Technique...3-9 Ordering Information... 10-13 Indication... 14 1 Clotalyst Autologous Activation
More informationArthrex Angel TM System. Indication-specific PRP and PRF gel preparations
Arthrex Angel TM System Indication-specific PRP and PRF gel preparations Arthrex Angel TM System The Arthrex Angel TM System is a revolutionary production system for platelet-rich plasma (PRP) formulations
More informationProduct Information as approved by the CHMP on 15 November 2012, pending endorsement by the European Commission
Product Information as approved by the CHMP on 15 November 2012, pending endorsement by the European Commission ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT EVICEL solutions
More informationDescription. Used materials. Warnings and precautions
USER MANUAL Description The GPS II System separates the blood components, present in blood, on the basis of density, through application of the GPS -Thermo International Equipment Company (IEC)-Centrifuge.
More informationThese handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides.
These handouts are only meant as a guide while you follow the presentation on the screen. Sometimes the speaker will change some of the slides. If you would like the 1 slide per page handouts, please ask
More informationD-Stat Dry Topical Hemostat Proven to Reduce Time-to-Hemostasis 1,2
D-Stat Dry Topical Hemostat Proven to Reduce Time-to-Hemostasis 1,2 Clinical Data to Support a True Hemostat Results are from a 376-patient, five-center, prospective randomized U.S. clinical study evaluating
More informationManejo de la transfusión de plaquetas. Ileana López-Plaza, MD
Manejo de la transfusión de plaquetas Ileana López-Plaza, MD Thrombocytopenia Common in ICU setting 25-38% with< 100,000/µL 2-3 % with < 10,000/µL Common etiologies Drug-induced: heparin, antibiotics,
More informationThe Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management. Elham Khalaf Adeli
The Role Of Point of Care Coagulation Testing (POCCT) in Patient Blood Management Elham Khalaf Adeli Overview PBM, bleeding management, Coagulation POC Testing Review of laboratory conventional coagulation
More informationThe Clinical Use and Immunologic Impact of Thrombin in Surgery
The Clinical Use and Immunologic Impact of Thrombin in Surgery Jeffrey H. Lawson, M.D., Ph.D. Departments of Surgery and Pathology Duke University Medical Center Durham, North Carolina Bovine Thrombin
More informationDisclosures. Thromboelastography. TEG Methodology. TEG Output. Thromboelastography (TEG): Basics & Clinical Applications
Thromboelastography (TEG): Basics & Clinical Applications Paula J. Santrach MD Associate Professor, Laboratory Medicine Mayo Clinic Rochester, MN Disclosures Relevant financial relationships NONE Off label
More informationBlood Product Utilization
Who gets what & when Why not to give blood? Volume Expander For specific number (except as related to procedures) To patients with religious objections to blood transfusions Blood given only when necessary
More informationEach TISSEEL Lyo contains 4 vials. The active ingredients are:
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT TISSEEL Lyo Two-Component Fibrin Sealant 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each TISSEEL Lyo contains 4 vials. The active ingredients
More informationDatabase Review of Possible Factors Influencing Point-of-Care Platelet Gel Manufacture
The Journal of The American Society of Extra-Corporeal Technology Database Review of Possible Factors Influencing Point-of-Care Platelet Gel Manufacture Jonathan H. Waters, MD;* K.C. Roberts, MS, CP, CCA
More information2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active substances Human fibrinogen, Coagulation Factor XIII (human), Aprotinin (bovine)
1. NAME OF THE MEDICINAL PRODUCT 0.5 ml, 1 ml, 3 ml Powders and solvents for sealant. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Qualitative composition Combi-Set I: Active substances Human fibrinogen,
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT EVICEL solutions for sealant 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The active ingredients are as follows: Component 1
More informationCategory Storage Shelf Life Additional Criteria
CE Update [blood banking/transfusion medicine] Blood Components for Hemostasis Jun Teruya, MD, DSc, and Glenn Ramsey, MD From the Department of Pathology, Northwestern University Medical School, Chicago.
More information31st 31 Annual Controversies, Problems a nd and and Techniques Techniques in
31 st Annual Controversies, Problems and Techniques in Surgery Michael J. Rosen MD, FACS Professor of Surgery Director, Cleveland Clinic Comprehensive Hernia Center Cleveland Clinic Foundation Cleveland
More informationHEMOSTASIS IN SURGERY
Greco D.P.- M.D.-F.A.C.S. Director SSD Day Surgery Torino 25-27 november 2010 HEMOSTASIS IN SURGERY The normal physiological response that prevents significant blood loss following vascular injury is called
More informationPREVELEAK Surgical sealant
PREVELEAK Surgical sealant Rx only Instructions for Use DEVICE DESCRIPTION PREVELEAK Surgical sealant (PREVELEAK) is a sealant developed to seal suture holes formed during surgical repair of the circulatory
More informationNational Institute for Health and Care Excellence Medical Technologies Evaluation Programme
National Institute for Health and Care Excellence Medical Technologies Evaluation Programme MT205 ReCell Spray-On Skin MT205 - The ReCell Spray-On Skin system for treating skin loss, scarring and depigmentation
More informationT HE DEMONSTRATION of the effectiveness of fibrin foam as an agent for
FURTHER USES OF GELATIN FOAM IN NEUROSURGERY* EDGAR F. FINCHER, M.D. Department of Surgery, Emory University School of Medicine, Atlanta, Georgia (Received for publication October 12, 1946) T HE DEMONSTRATION
More informationANEMIA. Oral iron. IV iron gluconate (order set #233)
PREVENTION ANEMIA Oral iron IV iron gluconate (order set #233) TRANSEXAMIC ACID Efficacy of IV TXA in Reducing Blood Loss After Elective C-section: Prospective, Randomized, Double-blind, Placebo Controlled
More informationSee 17 for PATIENT COUNSELING INFORMATION. Revised: 9/2017
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TACHOSIL safely and effectively. See full prescribing information for TACHOSIL. TACHOSIL Fibrin Sealant
More informationPlatelet Factor IV- Heparin Antibodies. Presenter: Michael J. Warhol, M.D.
Platelet Factor IV- Heparin Antibodies Presenter: Michael J. Warhol, M.D. Learning Objectives Describe the mechanism of interaction between Heparin and Platelet Factor 4 Review the chemistry of Heparin
More informationPublic Health Service DEPARTMENT OF HEALTH & HUMAN SERVICES
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service April 26, 2007 FDod and Drug Administration Center for Biologies Evaluation and Research 1401 Rockville Pike Rockville MD 20852-14M By Certified
More informationSection 8. To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS)
Section 8 Practicalities Blood Collection Aim To introduce the basic theory and principles of collecting blood for Intraoperative Cell Salvage (ICS) Learning Outcomes To identify the equipment used for
More informationCh 13: Blood. What does blood do? Transport: Regulation: Protection:
Ch 13: Blood What does blood do? Transport: Regulation: Protection: SLOs Describe the composition of plasma and list the major functions of plasma proteins. Map hematopoiesis, starting from a pluripotent
More informationPlatelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.
Platelet Concentrate in Total Knees BIOLOGICS This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees Total Knee Arthroplasty Total
More informationPRODUCT MONOGRAPH EVICEL. 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits. Fibrin Sealant Kit Ph. Eur. Haemostatic Agent
PRODUCT MONOGRAPH EVICEL 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits Fibrin Sealant Kit Ph. Eur. Haemostatic Agent Component Human Clottable Protein: Human Thrombin: Strength Factor XIII 50-90 mg/ml 2-15 IU/mL
More informationPRODUCT MONOGRAPH EVICEL. 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits. Fibrin Sealant Kit Ph. Eur. Haemostatic Agent
PRODUCT MONOGRAPH EVICEL 2 x 1 ml, 2 x 2 ml & 2 x 5 ml Kits Fibrin Sealant Kit Ph. Eur. Haemostatic Agent Component Human Clottable Protein: Human Thrombin: Strength Factor XIII 50-90 mg/ml 2-15 IU/mL
More informationDuraGen Secure. Dural Regeneration Matrix
DuraGen Secure Dural Regeneration Matrix DESCRIPTION DuraGen Secure Dural Regeneration Matrix is an absorbable implant for the repair of dural defects. DuraGen Secure Dural Regeneration Matrix is an easy
More informationProduct Data Sheet - TRUEMAB
888.267.4436 techsupport@origene.com www.origene.com Name:F13A1 (Factor XIIIa) mouse monoclonal antibody, clone OTI3E3 (formerly 3E3) Product Data Sheet - TRUEMAB Catalog: TA800346 Components: F13A1 (Factor
More informationNew factor concentrates on the way to the market
New factor concentrates on the way to the market ISCB, Copenhagen, 1 September 2015 John R. Hess, MD, MPH, FACP, FAAAS Professor of Laboratory Medicine and Hematology Medical Director, Transfusion Service,
More informationCoagulopathy Case-2. Andy Nguyen, M.D. 2009
Coagulopathy Case-2 Andy Nguyen, M.D. 2009 CLINICAL HISTORY A 42 year-old man brought to the emergency room with severe burn. Patient was rescued by firemen in a serious fire. He had been found unconscious
More informationHistoacryl Flexible Improved closure of surgical incisions
Improved closure of surgical incisions Closure Technologies Improved closure of surgical incisions New NEW! The new generation of Histoacryl glue has been designed to close and protect surgical wounds.
More informationInnovative Uses of Adhesives in Anterior Segment Surgery. Financial Disclosure
Innovative Uses of Adhesives in Anterior Segment Surgery Christopher J. Rapuano, M.D. Director, Cornea Service Co-Director, Refractive Surgery Department Wills Eye Hospital Professor, Jefferson Medical
More informationFORWARD LOOKING STATEMENT
FORWARD LOOKING STATEMENT Statements made in this presentation that look forward in time or that express management's beliefs, expectations, hopes or predictions of the future are forward-looking statements
More informationHistoacryl A revolution in mesh fixation
Histoacryl A revolution in mesh fixation Closure Technologies Histoacryl A revolution in mesh fixation A new indication for a classic product Histoacryl has been used for more than 40 years in operating
More informationAdvance approaches for skin closure
ISSN: 2319-7706 Volume 3 Number 1 (2014) pp. 18-22 http://www.ijcmas.com Review Article Advance approaches for skin closure Anu Sangwan 1*, Kuldeep Sharma 2 and Nagesh Binjoo 3 1 Department of Biochemistry,
More informationMaría Luisa Navarrete Álvaro, 1 N. Ortiz, 1 L. Rodriguez, 2 R. Boemo, 1 J. F. Fuentes, 1 A. Mateo, 1 and P. Ortiz 2. 1.
International Scholarly Research Network ISRN Surgery Volume 2011, Article ID 451020, 4 pages doi:10.5402/2011/451020 Research Article Pilot Study on the Efficiency of the Biostimulation with Autologous
More informationAPPLICATION OF AUTOLOGOUS PLATELET RICH PLASMA (APRP) AS AN ADJUVANT THERAPY IN PLASTIC SURGERY
Plastic Surgery Original Article International Journal of Clinical And Diagnostic Research ISSN 2395-3403 Volume 4, Issue 6, Nov-Dec 2016. Glorigin Lifesciences Private Limited. APPLICATION OF AUTOLOGOUS
More informationPRP Preparation. Simplicity for Success
PRP Preparation Simplicity for Success Features and Benefits of the Tropocells System Effectiveness Enables high platelet concentration by reducing the volume of plasma. Rapid and simple one step process
More informationHemostats - Medical Devices Pipeline Assessment, 2016
Hemostats - Medical Devices Pipeline Assessment, 2016 Hemostats - Medical Devices Pipeline Assessment, 2016 Sector Publishing Intelligence Limited (SPi) has been marketing business and market research
More informationProduct Data Sheet - TRUEMAB
888.267.4436 techsupport@origene.com www.origene.com Name:F13A1 (Factor XIIIa) mouse monoclonal antibody, clone OTI1H2 (formerly 1H2) Product Data Sheet - TRUEMAB Catalog: TA800305 Components: F13A1 (Factor
More information